Living-donor liver transplant for HAV induced acute liver failure

  • Dr. Swanand A Redekar DNB Medical Gastro Final Year Trainee, Shivani hospital and IVF Research Center, Kanpur, Uttar Pradesh, India
  • Dr. Shivanshu Misra Consultant Bariatric Surgery and Advanced Laparoscopic Surgeon, Shivani hospital and IVF Research Center, Kanpur, Uttar Pradesh, India https://orcid.org/0000-0001-5160-6211
Keywords: Acute liver failure (ALF), HAV (Hepatitis A Virus), Living donor liver transplant

Abstract

Though HAV infection is prevalent in the general population, HAV-induced ALF is very rare.ALF due to HAV are more common in elder patients’ group, and it has a worse prognosis. A 23-year-old south Indian male presented with fever, jaundice, and malaise, who had positive anti HAV IgM antibodies, developed hepatic encephalopathy which ultimately led to a diagnosis of acute liver failure due to acute hepatitis A virus infection. Despite the failure of supportive treatment, he was managed successfully with a living donor liver transplant.

Downloads

Download data is not yet available.

References

Mendizabal M, Silva MO. Liver transplantation in acute liver failure: A challenging scenario. World J Gastroenterol. 2016;22(4):1523-1531. doi: https://doi.org/10.3748/wjg.v22.i4.1523.

Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology (Baltimore, Md.). 2012;55(3):965-967. doi: https://dx.doi.org/10.1002%2Fhep.25551.

Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen‐induced acute liver failure. Hepatol. 1998;27(4):1050-1055. doi: https://doi.org/10.1002/hep.510270421.

Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006;28(1):101-111. doi: https://doi.org/10.1093/epirev/mxj012.

Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, et al. US Acute Liver Failure Study Group. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatol. 2006;44(6):1589-1597. doi: https://doi.org/10.1002/hep.21439.

Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New Engl J Med. 1998;338(5):286-290. doi: https://doi.org/10.1056/nejm199801293380503.

McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53(3):492-499. doi: https://doi.org/10.1016/j.jhep.2010.03.023.

Ciocca M, Moreira-Silva SF, Alegría S, Galoppo MC, Ruttiman R, Porta G, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J. 2007;26(8):711-715. doi: https://doi.org/10.1097/inf.0b013e3180f60bed.

Jung DH, Hwang S, Lim YS, Kim KH, Ahn CS, Moon DB, et al. Outcome comparison of liver transplantation for hepatitis A‐related versus hepatitis B‐related acute liver failure in adult recipients. Clin Transplant. 2018;32(1):e13140. doi: https://doi.org/10.1111/ctr.13140.

CITATION
DOI: 10.17511/ijoso.2020.i03.14
Published: 2020-06-30
How to Cite
A Redekar, S., & Misra, S. (2020). Living-donor liver transplant for HAV induced acute liver failure. Surgical Review: International Journal of Surgery, Trauma and Orthopedics, 6(3), 220-222. https://doi.org/10.17511/ijoso.2020.i03.14
Section
Case Report